Elevated Prx1 Provides Resistance to Docetaxel, But Is Not Associated with Predictive Significance in Lung Cancer.
- Author:
Ki Eun HWANG
1
;
Chul PARK
;
Chang Hwan SEOL
;
Yu Ri HWANG
;
June Seong HWANG
;
Jae Wan JUNG
;
Keum Ha CHOI
;
Eun Taik JEONG
;
Hak Ryul KIM
Author Information
- Publication Type:Original Article
- Keywords: PRDX1 Protein, Human; Docetaxel; Lung Neoplasms
- MeSH: Animals; Apoptosis; Axis, Cervical Vertebra; Carcinoma, Non-Small-Cell Lung; Disease-Free Survival; Hand; Humans; Lung; Lung Neoplasms; Mice; Mice, Nude; Peroxiredoxins; Taxoids; Transplantation, Heterologous
- From:Tuberculosis and Respiratory Diseases 2013;75(2):59-66
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND: This study was conducted in order to elucidate the effects of docetaxel on the growth of peroxiredoxin 1 (Prx1) knockdown A549 xenograft tumors and further tested the role of Prx1 as a predictor for how a patient would respond to docetaxel treatment. METHODS: Effects of docetaxel on the growth of scrambled- and shPrx1-infected A549 xenograft tumors in nude mice were measured. Moreover, immunohistochemical expression of Prx1 was evaluated in paraffin-embedded tissues from 24 non-small cell lung cancer patients who had received docetaxel-cisplatin regimens as a first-line treatment. RESULTS: Docetaxel treatment in Prx1 knockdown xenograft tumor resulted in reduced tumors growth compared with other groups. Prx1 knockdown increased the production of cleaved caspases-8 and -9 in the control itself compared to scramble tumors. Moreover, docetaxel treatment in Prx1 knockdown tissue led to an increased protein band. Phosphorylated Akt was found in Prx1 scramble tissues. Phosphorylated FOXO1 was detected in the docetaxel treatment group. On the other hand, Prx1 knockdown completely suppressed the Akt-FOXO1 axis. The median progression-free survival (PFS) of patients with low Prx1 expression was 7 months (95% confidence interval [CI], 6.0-7.7), whereas the median progression-free survival of patients with high Prx1 expression was 4 months (95% CI, 4.0-5.0). However, high Prx1 expression was not associated with decreased PFS (p=0.114). CONCLUSION: Our findings suggest that elevated Prx1 provides resistance to docetaxel treatment through suppression of FOXO1-induced apoptosis in A549 xenograft tumors, but may not be related with the predictive significance for response to docetaxel treatment.
